SPIRAMYCINE/METRONIDAZOLE TEVA 750.000 IU/125 mg, film-coated tablet 20 tablets
Active ingredients: Metronidazole, Spiramycin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIRAMYCINE/METRONIDAZOLE TEVA 750.000 UI/125 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 20 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61912415CIP73670534CIP133400936705340Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRAMYCINEcomprimé | 750 000 UI · un comprimé | SA |
| MÉTRONIDAZOLEcomprimé | 125 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.